Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001185945-25-000005
Filing Date
2025-10-14
Accepted
2025-10-14 16:10:05
Documents
1
Period of Report
2025-10-10

Document Format Files

Seq Description Document Type Size
1 form4-10142025_041001.html 4  
1 form4-10142025_041001.xml 4 7195
  Complete submission text file 0001185945-25-000005.txt   8926
Mailing Address C/O TENAX THERAPEUTICS, INC. ONE COPLEY PARKWAY, SUITE 490 MORRISVILLE NC 27560
Business Address
RALLIS CHRIS A (Reporting) CIK: 0001185945 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32295 | Film No.: 251391830

Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Issuer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)